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Muscimol, a psychoactive constituent of Amanita muscaria, activates all GABAA 
receptor subtypes with exceptionally high affinity to αβδ. This is explained by δ 
subunit role on muscimol extremely slow dissociation from these receptors. 
However, the contributions of GABAAR β subunit variant to the affinity state of 
αβδ receptors and function were not described in similar detail as α subunit 
variant in the literature. The extrasynaptic δ-containing receptors are in a great 
deal responsible for the so-called tonic inhibition in the brain. 
 
This study aims to understand the role of β1,2,3 subunits in muscimol binding to  
δ-containing extrasynaptic GABAA receptors. We performed transient 
expression of recombinant GABAAR subtypes in HEK293 cells and determined 
the association and dissociation rates of [3H]muscimol binding to recombinant 
α6β1δ, α6β2δ and α6β3δ receptors using radiolabeled binding kinetics 
approaches.  
 
α6β1,2,3δ recombinant receptors showed distinct binding kinetics. In α6β1δ and 
α6β2δ recombinant receptors, [3H]muscimol association was similar and 
significantly slower than α6β3δ. Moreover, dissociation of the binding was very 
slow especially to α6β2δ recombinant receptor compared to α6β1δ and α6β3δ 
that were similar. The remarkable slow dissociation of [3H]muscimol from all 
three receptor subtypes confirms the studies indicating α6β1-3δ high affinity 
state being independent of β subunit. 
 
Further electrophysiological studies are needed to reveal how different β 
subunits affect binding site of αβδ GABAA receptors in terms of ligand sensitivity 
and efficacy. This leads to an improved pharmacological characterization of 
extrasynaptic αβδ receptors and possible development of selective allosteric 
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1.1 GABAA receptors 
  
γ-Aminobutyric acid type A receptors (GABAAR) are key sites in rapid synaptic 
inhibition in vertebrate brain (Olsen & Sieghart, 2008). GABAARs contain an 
intrinsic chloride channel that is opened by the binding of GABA. The entrance 
of chloride ions into mature neurons leads to hyperpolarization and/or 
stabilization of the membrane potential and thus inhibition of the neuron 
(Macdonald & Olsen, 1994). The modulation of receptor function occurs through 
allosteric binding sites by different clinically significant drugs, such as 
benzodiazepines, steroids, anesthetics and barbiturates (Sieghart, 1995) which 
indicates the central role of GABAARs as targets for modulation of CNS 
excitability. 
 
1.2 Molecular and pharmacological subtypes of GABAARs 
  
Molecular cloning has identified 19 mammalian genes that code for GABAAR 
hetero-oligomeric protein subunits which belong to 8 subunit classes: α1-α6, 
β1-β3, γ1-γ3, δ, ε, π, θ and ρ1-ρ3 (Olsen & Sieghart, 2008). Brain regional 
subunit mRNA expression is heterogeneous with cell-type specificity (Laurie et 
al., 1992; Wisden et al., 1992). This produces receptor subtypes with distinctive 
functional and pharmacological properties. Differential distribution of receptor 
subtypes in the CNS enables development of drugs that act on a receptor 
subtype with restricted regional localization in the brain. With subtype-selective 
drugs it may be possible to modulate specific physiological functions without 
undesirable side effects. 
Most GABAARs are pentameric complexes that contain α, β and γ subunits 
where subunit stoichiometry is 2α:2β:1γ (Figure 1) (Tretter et al., 1997). The γ 
subunit is needed for binding of classical benzodiazepines as γ2 subunit is 
considered as the γ isoform present in over 90% of αβγ receptors (Pritchett et 
al., 1989; Wisden et al., 1992; McKernan & Whiting, 1996). γ2 associates with 
all α subunits, the subunit class mainly determining benzodiazepine 






with a point mutation rendering the respective α subunit benzodiazepine-
insensitive have indicated the mediation of benzodiazepine-induced sedation 
and amnesia by receptors containing α1 and anxiolysis by receptors containing 
α2, respectively (Möhler et al., 2002). Receptors that do not contain a γ subunit 




Fig. 1. GABAA receptor subunit composition (Uusi-Oukari and Korpi, 2010) 
1.3 Synaptic GABAARs mediate phasic inhibition 
 
Phasic inhibition is produced by inhibitory postsynaptic currents (IPSCs) that 
emerge from synaptic contacts during synaptic release of inhibitory transmitter 
which in turn transiently inhibits neurons for 10-100 milliseconds (Semyanov et 
al., 2004).This synaptic transmission is mediated by GABAARs clustered in 
postsynaptic densities. Postsynaptic clustering of GABAA receptor subtypes 
α2βγ2 and α3βγ2 is induced by interaction of α2 and α3 subunits with gephyrin 
(Wu et al., 2012), a multifunctional protein that serves as a sub-synaptic 
scaffold organizing the spatial distribution of receptors and other proteins in 
inhibitory postsynaptic membranes. The interaction of α1-3βγ2 GABAA receptors 
with the postsynaptic cytoskeleton is regulated by the activity-dependent and 
calcineurin-regulated phosphorylation state of γ2 subunit. Transmembrane 
domain 4 and intracellular domain of the γ2 subunit has been shown to be 
essential for recruiting gephyrin to the synapse. The role of gephyrin is to 






Therefore, synaptic GABAARs are of αβγ-type receptors where the classic 
benzodiazepines predominantly augment the synaptic (phasic) inhibition. 
1.4 Extrasynaptic GABAARs mediate tonic inhibition 
 
The continuous activation of extrasynaptic GABAARs by ambient GABA results 
in tonic inhibition. Extrasynaptic GABA originates when GABA escapes from 
synaptic cleft (GABA spill-over) (Brickley et al., 1996; Mitchell & Silver, 2000; 
Semyanov et al., 2003) or when GABA is released through unconventional 
mechanism (possibly non-vesicular) from neurons and glia (Wang et al., 2002; 
Demarque et al., 2002; Lee et al., 2010). Extrasynaptic receptor subtypes 
mediating tonic inhibition mainly include δ subunit-containing receptors (Nusser 
et al., 1998; Nusser & Mody, 2002; Stell & Mody, 2002). They possess 
characteristics needed for tonic activity since they have very high GABA-affinity 
and hence get activated by low GABA concentrations. Moreover, they do not 
desensitize upon a prolonged presence of GABA (Saxena & Macdonald, 1996) 
thus being able to maintain continuous inhibition.  
 
1.5 Expression of δ-containing GABAARs in the CNS 
  
γ2 and δ subunits are assembled into separate receptors, and δ is present only 
in α6/4β-containing extrasynaptic combination (Quirk et al., 1995; Jechlinger et 
al., 1998; Pöltl et al., 2003). A significant group of GABAARs especially in 
cerebellar granule cells (CGC) are those containing the δ subunit (Quirk et al., 
1995; Sur et al., 1999). From the second postnatal week CGCs express six 
main GABAAR subunit isoforms throughout the adulthood: α1, α6, β2, β3, γ2 
and δ (Laurie et al., 1992; Jechlinger et al., 1998;  Pöltl et al., 2003). Brain 
regional expression of α6 is restricted to CGCs, while α1, β2, β3 and γ2 are 
expressed highly in most of the brain regions (Lüddens et al., 1990; Laurie et 
al., 1992). Combinations α1βγ2, α6βγ2 and α6βδ have been shown to be the 
major receptor subtypes in CGCs (Jechlinger et al., 1998; Pöltl et al., 2003). In 
hippocampus δ subunit is expressed mainly in dentate granule cells (DGC) 
(Wisden et al., 1992). In these cells δ combines with α4 and β subunits to form 
α4βδ receptors (Sur et al., 1999). These receptors have been implicated in 






Mody, 2002; Stell & Mody, 2002). In addition to CGCs and DGCs, δ is highly 
expressed in thalamus and in moderate levels in cerebral cortex and in nucleus 
accumbens (NAc) (Wisden et al., 1992). 
1.6 Up-regulation of extrasynaptic δ-containing receptors and brain 
function 
 
Delta subunit expression is drastically up-regulated in rodent neurons in vitro by 
various types of glutamatergic depolarization (Gault & Siegel., 1998; 
Martikainen et al., 2004; Salonen et al., 2006; Uusi-Oukari et al., 2010). At 
present it is not known whether this up-regulation of GABAAR subunit mediating 
tonic inhibition occurs in living brain during prolonged excitation. However, in 
stargazer mutant mice that lack functional stargazing, a protein regulating 
synaptic targeting and anchoring of AMPARs (Letts, 2005; Osten & Stern-Bach, 
2006), extrasynaptic α4βδ and α6βδ GABAARs are drastically down-regulated 
(Payne et al., 2006; Payne et al., 2007). This suggests that AMPAR activity up-
regulates αβδ receptor expression also in vivo. Significant alterations occur in 
brain glutamate levels and/or in glutamate receptors sensitivity during epileptic 
seizures, cerebrovascular ischaemia and alcohol withdrawal (Chapman, 1998; 
Dirnagl et al., 1999; Dodd et al., 2000). This suggests that up-regulation of 
GABAAR δ subunit may be a mechanism to reduce overexcitation in these 
conditions. This hypothesis is supported by the recent findings that tonic 
inhibition mediated by δ-containing GABAARs was strongly increased in 
DGGCs after traumatic brain injury (Mtchedlishvili et al., 2010; Kharlamov et al., 
2011) and in pilocarpine-induced status epilepticus (Zhan & Nadler, 2009). The 
important role of α4βδ receptors in neuroprotection was demonstrated in striatal 
slices where muscimol efficiently protected neurons against quinolinic acid-
induced excitotoxic insults in wild-type but not in δKO mice slices (Santhakumar 
et al., 2010). 
 
1.7 The role of β subunit variant in GABAA Receptors 
 
In native GABAAR, β1 is known to be a rare subunit expressed mainly in cortex, 
hypothalamus and hippocampus. β2 and β3 equally represent almost 50% of all 






striatum, cortex and olfactory bulb. β2 is also highly expressed in thalamus (Lee 
and Maguire, 2014). The contribution of GABAAR β subunit variant to ligand 
affinity and receptor function has not been studied as extensively as α subunit 
variant. One reason could be the limitation of allosteric modulators binding 
selectivity to β1, β2, or β3 subunits. Nevertheless, Thompson et al., 2004 
reported on salicylidene salicylhydrazide, a negative allosteric modulator which 
selectively inhibits β1 containing GABAARs with high potency. Moreover, 
several genetic models were produced to understand the role of beta subunits 
in animal behavior. Mouse models with β2 knockout displayed elevation in 
locomotor activity and decreased response to benzodiazepines and GABA (Sur 
et al., 2001). β3 knockouts are used as mouse model for Angelman syndrome. 
They exhibit extensive loss of GABAARs in CNS and only 10% survive within 
the first day. Increased activity, excitability, seizures and deterioration in motor 
performance were reported (Resnick et al., 1999; Krasowski et al., 1998; 
Homanics et al., 1997a; DeLorey et al., 1998). On the other hand, animal 




Muscimol is the principal psychoactive constituent of Amanita muscaria and 
related species of mushroom broadly used as a lead compound for drug 
development (Krogsgaard-Larsen et al., 1981). It is a conformationally restricted 
GABAA-analog and agonist that activates all GABAAR subtypes (Krogsgaard-
Larsen et al., 1979; Ogurusu et al., 1999). However, it acts as a superagonist 
with exceptionally high affinity to αβδ subtypes (Storustovu & Ebert, 2006; 
Quirck et al., 1995). The moderate superagonist behavior of muscimol on αβδ 
receptors is caused by reduced desensitization of αβδ receptors (Mortensen, 
2010). 
 
An earlier study revealed the slow association and dissociation rates of 
[3H]muscimol binding to recombinant α6β2δ GABAA receptors (Taina, 2013). 
The association rate constant for α6β2δ subtype was 3.8-4.4-fold lower 
compared to α6β2γ2 recombinant receptors, but the difference didn’t reach 
statistical significance. Dissociation of [3H]muscimol was very slow from α6β2δ 






subtype. Hence, the high affinity of muscimol to αβδ receptors is suggested to 
be due to its extremely slow dissociation from these receptors.  
 
Whether endogenous GABA shows similar binding kinetics as [3H]muscimol on 
α6β2δ and α6β2γ2 recombinant receptors needs to be investigated. Moreover, 
using radiolabeled binding kinetics approaches, the association and 
dissociation rates of [3H]muscimol binding to recombinant α6β1δ, α6β2δ and 
α6β3δ GABAA receptors are measured in this study. This gives a better 
understanding on the role of β1, β2, β3 subunits in muscimol binding to delta-
containing extrasynaptic GABAA receptors. 
 
2. RESULTS 
2.1 Association of [3H]GABA to recombinant  GABAAR subtypes 
 
Results showed that the association of [3H]GABA at room temperature to α6β2δ 
recombinant receptors was slower compared to α6β2γ2 (Figure 2). Two-way 
ANOVA analysis revealed a significant receptor subunits effect on [3H]GABA 
association, F(1,24) = 10.04, MSE = 47.2, p < 0.05 (Bonferroni post hoc test) 
indicated that the association to α6β2δ was significantly slower than α6β2γ2 at 
1 and 2 min time points (p < 0.05). An independent-sample t-test showed that 
there was a significant difference in [3H]GABA association rate constants (kon)  
in between the receptor subtypes t(4) = 4.315, p < 0.05, two-tailed. The 
association rate constant in α6β2δ subtype was 5.6 lower as compared to 
α6β2γ2 (Table1). The overall goodness of fit for the association curves were R2 
= 0.55 and 0.19 for α6β2δ and α6β2γ2 respectively. 
 
Table 1: Association (kon) rate constant of [
3H]GABA binding at room 
temperature in recombinant receptors expressed in HEK293 cells. 
Recombinant Receptor kon (M
-1 x min-1) 
 
± SEM 
α6β2δ 7.42 x 10
7 1.08 x 107 
α6β2γ2 41.4 x 10






   
Fig. 2. Association of [3H]GABA binding at room temperature to recombinant 
α6β2δ and α6β2γ2 receptors expressed in HEK293 cells (mean ± SEM; n=3). 
2.2 Dissociation of [3H]GABA from recombinant  GABAAR subtypes 
 
The dissociation of [3H]GABA from α6β2δ was very slow, significantly slower 
than α6β2γ2 subtype (Figure 3). Hence, the receptor subunit combinations 
significantly affected the dissociation (receptor subtype effect:   F(1,12) = 101.2, 
MSE = 46.05, p < 0.0001; two way ANOVA). As a follow up test, Bonferroni 
post hoc analysis indicated that dissociation from α6β2δ was significantly 
slower than α6β2γ2 at 30 s, 60 s (p < 0.0001) and 3 min. (p < 0.05). Results 
also showed that 50% of [3H]GABA was unbound from α6β2δ receptor at 99 s 
compared to α6β2γ2 receptor from which 50% was unbound at 19.2 s. At 30 
min of dissociation, there was still [3H]GABA remained bound  to the 
recombinant receptors, 22% to α6β2δ and 7% to α6β2γ2 (Fig. 4). Furthermore, 
the dissociation (koff) rate constant in α6β2δ was significantly lower than 







Fig. 3. Dissociation of [3H]GABA binding at room temperature from α6β2γ2 and 
α6β2δ receptors. The dissociation from the δ containing receptor subtype 
(α6β2δ) was slower (koff = 0.42 ± 0.07 min
-1) compared to α6β2γ2 (koff = 2.16 ± 
0.23 min-1) (mean ± SEM; n=3). 
 
2.3 Association of [3H]muscimol to recombinant  GABAAR subtypes 
  
The binding kinetics measurements of [3H]muscimol at room temperature 
showed slow association especially for α6β1δ and α6β2δ compared to α6β3δ 
recombinant receptors (Figure 4). Nevertheless, at least 90% of maximal 
[3H]muscimol binding level was reached to each of the three receptor subtypes 
at 8 min. There was a significant subunit effect observed on association 
(receptor subtype effect: F(2,36) = 9.53, MSE = 23.8, p < 0.05; two-way 
ANOVA). Post Hoc analysis using Bonferroni test revealed that [3H]muscimol 
association to α6β1δ and α6β2δ receptors was significantly slower than  α6β3δ, 
p < 0.05. However, the association to α6β1δ and α6β2δ subtype receptors was 
not significantly different. From Table 2, we note that [3H]muscimol association 
(kon) rate constant in α6β3δ was the highest. The association rate constants in 
α6β1δ and α6β2δ were significantly lower than α6β3δ (p < 0.001, one-way 
ANOVA, Tukey follow-up test). The difference in kon between α6β2δ and α6β1δ 






     
Fig. 4. Association of [3H]muscimol binding at room temperature to recombinant 
α6β1δ, α6β2δ and α6β3δ receptors expressed in HEK293 cells (mean ± SEM; 
n=3). 
 
2.4 Dissociation of [3H]muscimol from recombinant  GABAAR subtypes 
  
The dissociation of [3H]muscimol from α6β1δ, α6β3δ and especially α6β2δ was 
very slow (Figure 5). A two-way ANOVA analysis yielded a significant effect for 
receptor subunit on dissociation, F(2,40) = 5.72, MSE = 55.9, p < 0.05. 
Bonferroni post hoc test showed that dissociation from α6β1δ and α6β3δ 
subtype receptors was not significantly different. However, [3H]muscimol 
dissociation from α6β2δ was significantly slower than α6β1δ and α6β3δ, p < 
0.05. The dissociation curve (Fig. 5) indicated that 50% of [3H]muscimol was 
unbound from α6β2δ receptor at 11 min compared to α6β1δ and α6β3δ (4-5 
min). Moreover, 31% of [3H]muscimol remained bound to α6β2δ at 30 min of 
dissociation. The results indicated that [3H]muscimol dissociation (koff) rate 
constant in α6β2δ was the lowest compared α6β1δ and α6β3δ (Table 2). 
Dissociation rate constant difference was statistically significant for α6β2δ vs. 
α6β1δ, p < 0.01 and α6β2δ vs. α6β3δ, p < 0.01, but not significant for α6β1δ vs. 










Fig. 5. Dissociation of [3H]muscimol binding at room temperature from α6β1δ 
(n=3), α6β2δ (n=4) and α6β3δ (n=4) recombinant receptors expressed in 
HEK293 cells. 
 
Table 2. Association (kon) and Dissociation (koff) rate constants of 
[3H]muscimol binding at room temperature in recombinant receptors 












α6β1δ 2.96 ± 0.47 x 10
7 0.17 ± 0.02**  5.74 
α6β2δ 3.42 ± 0.40 x 10
7 0.06 ± 0.01* 1.75 
α6β3δ 6.41 ± 0.45 x 10
7 ## 0.13 ± 0.01 2.03 
 
Statistical comparison of recombinant receptor kon values: 
##p < 0.01, 
significantly different from α6β1δ and α6β2δ values (one-way ANOVA 
followed by Tukey’s post hoc test). Statistical comparison of recombinant 
receptor koff values:**p < 0.01, significantly different from α6β2δ value; *p < 
0.05, significantly different from α6β3δ value (one-way ANOVA followed by 











This study aims to investigate the binding kinetics of [3H]GABA and 
[3H]muscimol in αβδ GABAA receptors, assess muscimol affinity and examine 
the difference in its binding properties to the recombinant α6β1δ, α6β2δ and 
α6β3δ GABAARs. 
 
3.1 GABA slows binding kinetics in recombinant αβδ GABAARs 
 
It is clearly shown in the present study that δ subunit in GABAAR combinations 
have a role in slowing the rate of [3H]GABA association and dissociation from 
recombinant receptors. On the other hand, γ2 subunit in GABAAR combinations 
leads to faster association and dissociation. The impact of slow dissociation for 
δ subunit was similarly shown for [3H]muscimol on native and recombinant αβδ 
GABAARs (Taina, 2013). [
3H]GABA association rate constant (kon) for α6β2δ is 
only 18% of the corresponding α6β2γ2 value. These findings are in 
correspondence with the studies on Xenopus oocytes that showed a significant 
low GABA efficacy on α6β2δ recombinant receptors. GABA-stimulated maximal 
currents for α6β2δ were only 21% of α6β2γ2 maximal currents (Hadley & Amin 
2007). Chandra et al. (2010) reported that the behavioral effects of muscimol in 
gene-modified mouse lines were dependent on the presence of α6, α4 and δ 
subunits. However, the slow dissociation contribution to muscimol behavioral 
effects is less probable since it is similarly observed for [3H]GABA on α6β2δ 
recombinant receptors. 
 
3.2 Muscimol has high affinity to δ containing GABAARs 
 
It has been found that muscimol has high affinity binding sites in cerebellar 
α6βγ2 and especially in α6βδ receptors (Quirk et al., 1995, Korpi et al., 2002). 
The slow and prolonged nature of tonic inhibition mediated by extrasynaptic δ-
containing receptors (Mody, 2001) correlates with the slow dissociation of both 
[3H]GABA and [3H]muscimol. The half-life of ligand-receptor interaction is 
known to be long for muscimol (Curran et al. 2002) and in the present study, 
[3H]muscimol dissociation rate constant (koff) in α6β2δ is even 7 times lower 






inversely proportional to affinity, is determined by the ratio of dissociation rate 
constant koff and association rate constant kon (KD = koff/ kon). The association 
rate of [3H]muscimol to δ-containing receptors is slow. This clearly concludes 
that muscimol’s remarkable high affinity to δ-containing GABAARs is due to its 
slow dissociation, which explains its moderate "superagonism" behavior. 
 
As muscimol is a conformationally restricted GABAA-analog, similarly with the 
endogenous GABA, it binds in zwitterionic form (Figure 6.) through two 
receptor-associated agonist binding sites (Chandra et al., 2010). Muscimol 
structure is more rigid than GABA due to its isoxazole ring. However, the 
polarized amino and carbonyl groups of muscimol interact with the same 
binding site residues as amino and carboxyl groups of GABA. This was 
explained by molecular docking methods suggesting that water is bound to the 
GABA agonist orthosteric binding pocket in addition to muscimol (Bergmann et 
al., 2013; Petersen et al., 2014). 
 
 
Fig. 6. GABA and muscimol structures in zwitterionic form  
(Krogsgaard-Larsen et al., 1979) 
 
An earlier study reported fast association and dissociation of muscimol binding 
to αβγ2 recombinant receptors (Taina., 2013). However, drastic effects on 
[3H]muscimol association and dissociation are observed when γ2 subunit is 
replaced by δ subunit. The stoichiometry of αβδ receptors and its subunit 
assembly has not been determined precisely. Nevertheless, γ2 to δ subunit 
substitution from 2α:2β:γ2 to 2α:2β:δ is confirmed in Barrera et al. (2008). 
GABAA agonist binding sites are located at the two β(+)α(-) interfaces (Sigel 
and Buhr, 1997). 2α:2β:δ forms two GABAA agonist sites, one at each β(+)α(-) 
interface. Hence, delta subunit eventually interacts with the two βα subunit pairs 
by forming α(+)δ(-) and δ(+)β(-) interfaces with its adjacent subunits (Figure 7). 






high affinity is still unclear: whether muscimol acts as an antagonist, or it 
reactivates the receptor after deactivation without dissociating from the 
receptor. However, there is an evidence that agonist dissociation rates correlate 
inversely with binding affinity (Jones et al., 2001) supporting the claim that 
muscimol’s slow dissociation is the reason behind its high affinity to δ-
containing GABAARs.  
 
 
Fig. 7. GABAA agonist binding site at β(+)α(-) interfaces of αβδ GABAARs 
(Modified from Ramerstorfer, J. et al., 2011) 
 
3.3 The role of Beta subunit variant in binding properties and receptor 
function 
 
3.3.1 Ligand sensitivity and efficacy 
 
α6β1-3δ recombinant receptors show distinct binding kinetics profiles confirming 
the role of β1-3 subunits in the different binding properties of extrasynaptic δ 
containing GABAARs. The remarkable slow dissociation of [
3H]muscimol from 
all three receptor subtypes confirms the studies indicating α6β1-3δ high affinity 
state being independent of β subunit (Hadley & Amin, 2007) and supports the 
role of delta subunit in the slow binding kinetics discussed earlier. Nevertheless, 
this doesn’t exclude the role of different β subunits in terms of ligand sensitivity 
to δ containing GABAA receptors. Electrophysiologically, β1 and β3 containing 
α6βδ receptors are more sensitive to GABA and picrotoxin binding than α6β2δ 
receptors. (Hadley & Amin 2007; Karim, 2012). Similarly, [3H]muscimol 






not significantly differ in this study and are significantly faster than for α6β2δ 
recombinant receptors. Hence, there may be a relation between slower 
dissociation from β2 containing α6βδ receptors and their lower sensitivity to 
GABAA ligands which needs further confirmatory electrophysiological studies. 
 
The differences in [3H]muscimol association (kon) and dissociation (koff) rate 
constants in α6β1-3δ recombinant receptors was clearly due to the difference in 
β1, β2 and β3 subunits. Accordingly, these subunits are directly associated in 
the binding site itself. From a thermodynamic prospective, the relatively slower 
dissociation behavior of [3H]muscimol in α6β2δ combinations suggests that the 
free energy difference between the bound and unbound states is higher in 
α6β2δ compared to α6β1δ and α6β3δ combinations.  
 
The reciprocal of dissociation rate constant, known as the drug-target residence 
time (τ = 1/koff), has been shown to often predict in vivo efficacy better than 
binding affinity (Copeland et al., 2007; 2016; Pan et al., 2013). However, due to 
the longer drug-receptor occupancy, low dissociation rates may lower the 
therapeutic index (median toxic dose/median effective dose) for drug 
candidates. [3H]Muscimol dissociation rate constant (koff) is significantly lower 
for α6β2δ recombinant receptors given that there was no significant difference 
in [3H]muscimol affinity to α6β2δ and α6β3δ. Hence, muscimol may show 
higher efficacy on α6β2δ receptors despite the fact that GABA showed low 
efficacy to the same receptors in previous studies (Karim, 2012). However, 
confirmatory studies are needed to compare muscimol-induced maximum 
response from native and recombinant extrasynaptic α6βδ receptors. 
 
3.3.2 Alcohol sensitivity, anesthesia and sedation 
 
This study highlighted the difference in binding properties between α6β1δ, 
α6β2δ and α6β3δ recombinant receptors which is consistent with their 
distinguished receptor functions discussed in the literature. The faster 
association of [3H]muscimol to the exceptionally GABA-sensitive α6β3δ 
recombinant receptor (Storustovu & Ebert, 2006) compared to α6β2δ may be 
linked to β3 subunit role in mediating the in vivo effects of ethanol and general 






nucleus (Samson & Chappell, 2001a) and medial prefrontal cortex (Samson & 
Chappell 2001b) decreased ethanol self-administration, though the effect was 
seen at different doses.  
 
In contrast to relatively high ethanol concentrations needed to potentiate GABA 
responses in αβγ subunit combinations, GABA responses in δ-containing 
receptors are sensitive to considerably lower ethanol concentrations 
(Sundstrom-Poromaa et al., 2002; Wallner et al., 2003). The high alcohol 
sensitivity of tonic GABA currents has been demonstrated in a number of 
studies showing that tonic currents in dentate granule cells, as well as in 
cerebellar granule cells, but not in cells that do not express the δ subunit, are 
enhanced by low doses of ethanol (Carta et al., 2004; Wei et al., 2004; Hanchar 
et al., 2005; Liang et al., 2006).  
 
Studies showed that the inhibition of α6β3δ and α4β3δ GABAARs was 
enhanced by ethanol at low concentrations of 3 mM as mild intoxication effects 
on humans were experienced (Wallner et al., 2003; Hanchar et al., 2004). 
Noting that this concentration is 3.6 times lower than the blood alcohol content 
(BAC) driving limit in Finland (10.9 mmol/L). These enhancements were 
antagonized by Ro15-4513 reversing ethanol low concentration effect on these 
receptors. (Wallner et al., 2006). According to Hanchar et al. (2006) some 
benzodiazepine derivatives, including Ro 15-4513 that have been shown to act 
as an ethanol antagonists at GABAA receptors (Suzdak et al., 1986), bind to 
α6β3δ receptors. These benzodiazepines are “silent” having no effect on GABA 
responses. However, Ro 15-4513 is able to block ethanol potentiation of GABA 
responses in α6β3δ receptors (Wallner et al., 2006). On the other hand, 10 fold 
decrease in ethanol sensitivity was observed for β2 subunit containing αβδ 
GABAARs (Wallner et al., 2003). However, the matter remains controversial as 
several research groups were not able to replicate these finding for ethanol at 
low concentrations (≤ 30 mM) (Borghese et al., 2006). Several research groups 
suggested that δ subunit do not contribute in high alcohol sensitivity of 
recombinant receptors or tonic currents (Borghese et al., 2006; Yamashita et 
al., 2006; Borghese & Harris, 2007; Korpi et al., 2007). To justify, transfections 
with different cRNA ratios of α6:β3:δ in Xenopus oocytes produced at least four 






exposing variance in electrophysiological kinetic measurements (Hadley & Amin 
2007; Baur et al., 2009). Some studies indicate the importance of 
phosphorylation state (presence of protein kinase C-delta) on ethanol 
stimulated GABA responses in the hippocampus (Choi et al., 2008) and in fact 
PKC phosphorylates α4 and β3 but not δ subunit in the hippocampus 
(Abramian et al., 2010). 
 
A study by Jurd (2002) on mice showed how propofol and etomidate anesthetic 
effects can be lost by producing N256M point mutation in β3 subunit. This 
means that β3-subunit is possibly expressed more readily than β1 or β2 in 
α6βδ/α4βδ extrasynaptic GABAA receptors being essential targets for ethanol 
and general anesthetics (Wallner et al., 2003). In contrast, sedation but not 
anesthesia was mostly abolished in the case of β2 (N265S) mutant mice 
(Reynolds et al., 2003). Additionally, the sedative and hypnotic drug, 
methaqualone, was more effective in activating α6β2δ receptors than α6β3δ 
and showing negative modulation for α6β1δ receptors (Hammer, 2015). This 
reveals the role of β2-subunit in arbitrating the sedative effects of anesthetics. 
  
3.3.3 Beta subunit amino acid residues and binding kinetics 
 
There was no evidence supporting that α6β1δ would differ from α6β2δ in terms 
of [3H]muscimol association or α6β3δ in terms dissociation. On the other hand, 
the association and dissociation to α6β2δ and α6β3δ are different although the 
M2 domain of both β2 and β3 subunits have the same amino acid residue 
(asparagine) at position 265 (15′) (Wingrove et al., 1994). Hence, the results 
suggest that residue at 265 is not involved in association and dissociation 
differences of GABAA receptors containing different beta subunits. However, a 
domain in δ subunit amino acid sequence that confers high agonist sensitivity 
has been identified (You & Dunn, 2007). The importance of this segment on 









3.4 Extrasynaptic δ-containing receptors as potential targets for drug 
development 
 
Understanding different GABAA receptor subtypes in terms of their distinctive 
functional and pharmacological properties is essential for drug development. 
Subtype-selective drugs make it possible to modulate specific physiological 
functions with no undesirable side effects and less development of tolerance.  
 
Functional characteristics of extrasynaptic αβδ receptors differ from those of 
αβγ2 receptors. αβδ receptors have high affinity for GABA, insensitivity to 
benzodiazepines and high sensitivity to neurosteroids and Zn2+ (Semyanov et 
al., 2003; Mortensen & Smart, 2006; Stórustovu & Ebert, 2006). However, they 
offer a potential novel target for drug development. Several positive modulators 
acting selectively on α4/6βδ receptors have already been discovered (Wafford 
et al., 2009; Lewis et al., 2010; Hoestgaard-Jensen et al., 2010). One of the two 
imidazo[1,2-a]pyridines, DS1, acts as an agonist and positive allosteric 
modulator, while the other (DS2) acts as positive modulator of α4/6βδ receptor 
subtypes (Wafford et al., 2009). Positive allosteric modulators of 
dihydropyrimidinone class are also selective for αβδ-type receptors, although 
the potencies of the compounds are quite low (Lewis et al., 2010). AA29504, a 
close analogue to the β potassium channel opener retigabine, increases the 
potency and efficacy of GABA on α4β3δ receptors in vitro (Hoestgaard-Jensen 
et al., 2010). In addition, AA29504-induced activation of αβδ receptors has 
been shown to reverse recognition memory deficits in a rat phencyclidine model 
of schizophrenia (Damgaard et al., 2011). 
 
Extrasynaptic δ-containing receptors mediate tonic inhibition in the brain. 
Augmentation of tonic inhibition is needed in overexcited states like in epileptic 
seizures. Several lines of evidence suggested a role for malfunctioning δ-
containing receptors in epilepsy (Lewis et al., 2010). Ganaxolone, a 
neurosteroid, is an example of drug under development to treat seizures as well 
as the developmental disorder Fragile X Syndrome (Lozano et al., 2014). It acts 
as a selective modulator for extrasynaptic δ-containing GABAA receptors 
(Brickley and Mody, 2012). Furthermore, THIP (4,5,6,7-tetrahydroisoxazolo[5,4-






receptors as a superagonist (Krogsgaard-Larsen et al., 2004). THIP at high 
concentrations increases the duration of longer channel openings and their 
frequency on αβδ receptors resulting in longer burst durations. Gaboxadol has 
been shown to improve sleep quality as a very promising novel hypnotic (Ebert 
et al., 2008), but due to adverse effects its development as hypnotic drug was 
discontinued. Nevertheless, gaboxadol is currently under study for its 
therapeutic potential in Angelman syndrome and Fragile X syndrome since both 
disorders are associated with deficiencies in GABAAR mediated tonic inhibition   
(Lozano et al., 2014; Egawa et al., 2012). 
 
3.5 Methodical considerations and limitations 
 
Long incubation times (15 min, 30 min) may induce proteolysis in recombinant 
receptors homogenates and affect the overall binding. EDTA was included in 
cell detaching buffer in order to inhibit the proteolytic enzymes at the cell 
harvesting step. However, EDTA was not included in the assay buffer as it can 
effect [3H]muscimol and [3H]GABA binding results. Upon the termination of 
[3H]muscimol or [3H]GABA incubation, filtration and rinsing steps took a total 
time of 15 s. During this, dissociation of the binding can still take place which 
may affect the results especially at the short time points (15 s, 30 s). In order to 
minimize error, the washing buffer (10 mM Tris-HCl) was kept on ice bath to 
keep its temperature as low as possible (Taina, 2013). 
 
Ligand binding does not occur exclusively to the expressed GABAARs on 
HEK293 cells. Other binding may occur on undefined areas in the biological 
samples or on the glass fiber filters. Hence, specific binding was determined 
indirectly by measuring the non-specific binding and total binding 
independently. Moreover, similar to the typical electrophysiological 
measurements, the binding kinetics experiments were conducted at room 
temperature for better correlation. Ligand-receptor binding at low temperature 
leads to even slower association and dissociation compared to the results 
obtained. 
 
The association and dissociation curves are usually biphasic and may represent 






high and low affinity binding sites (Agey and Dunn, 1989). In binding assays we 
used low [3H]muscimol concentration (10 – 20 nM), hence most binding was 
observed at the high affinity state. Time points used were limited (7 for 
association and 6 for dissociation) making the curve fitting more convenient in 
“one binding site” model. That’s why only one rate constant was calculated for 
association and dissociation reflecting the rates in one phase only. 
 
An interesting observation was noted with the harvested HEK293 cells 
suspended in buffer containing glycerol 43% and stored at -20 ºC for 24 h. 
[3H]Muscimol binding assays showed higher DPM values indicating more 
binding with the transfected cells pretreated with glycerol. This effect was seen 
in all three α6β1-3δ recombinant receptors. A recent study by Gupta et al. (2017) 
showed the role of lipids in stabilizing the oligomeric state of membrane 
proteins. This suggests that glycerol is able to induce changes in the hetero-
oligomeric GABAARs expressed in HEK293 cells leading to higher affinity state. 
However, this observation was only seen with [3H]muscimol hence studies are 
needed for other ligands (e.g. [3H]EBOB, [3H]Ro15-4513 and [35S]TBPS) to 
confirm the role of glycerol in the binding affinity to different GABAA 
recombinant receptor binding sites. 
 
4. SUMMARY AND CONCLUSION 
  
This study measured [3H]muscimol binding kinetics in α6β1-3δ recombinant 
receptors expressed in HEK293 cells. Radiolabeled ligand binding assays 
showed distinct association and dissociation profiles in all three investigated 
recombinant receptors. The association rate of [3H]muscimol was highest in 
α6β3δ recombinant receptors while the dissociation rate in α6β2δ was lowest. 
[3H]Muscimol equilibrium dissociation constant was highest for α6β1δ reflecting 
its relative lower affinity state. This study confirms the role of β subunits in the 
different binding properties of extrasynaptic δ-containing GABAARs. Further 
electrophysiological studies are needed to reveal how different β subunits affect 
binding site of αβδ GABAARs in in terms of ligand sensitivity and efficacy. This 
leads to an improved pharmacological characterization of extrasynaptic αβδ 
receptors and possible development of selective allosteric modulators with 






5. MATERIALS AND METHODS 
 
5.1 Cell culture 
  
Human Embryonic Kidney cells known as HEK293 were used for their high 
transfection efficiency and expression of recombinant proteins. This cell line is 
widely used in neuroscience studies and was initially produced by culturing 
normal HEK cells with sheared adenovirus 5 DNA (Graham et. Al., 1977). Cell 
culture medium was prepared initially by adding 13.7 g DMEM powder 
(Dulbecco's modified Eagle's medium, Gibco, Gaithersburg, MD) and 3.7 g 
sodium bicarbonate in each 1 liter of Milli-Q water. The components were 
solubilized with magnetic stirrer and pH was measured using Single Pore pH 
electrode (Hamilton, Weilheim, Germany) and adjusted with HCl to reach pH of 
7.0. The medium was then sterile filtrated (Millipore Steripak™ Filters, Merck 
KGaA, Darmstadt, Germany) before the addition 10% fetal bovine serum (FBS) 
(Gibco, Gaithersburg, MD; USA), 50 000 U/l penicillin and 50 mg/l streptomycin 
(Sigma- Aldrich, St Louis, MO, USA). 
  
HEK293 cells with a passage number of 6 where retrieved on ice from liquid 
nitrogen storage tank. The frozen tube contained the cells suspended in DMEM, 
10% FBS and 10% dimethyl sulfoxide (J. T. Baker, Austin, TX, USA). The 
sample was quickly thawed in a water bath at 37°C and put on ice with addition 
of 1.5 ml of FBS. The tube was then centrifuged (1600 rpm for 2 min) before 
discarding the supernatant with pipetting. Cell pellet was suspended in 2 ml of 
warm (37 °C) culture medium and transferred to 100 mm cell culture dish 
(Corning, New York, USA). The cells were then grown in a total volume of 10 ml 
culture medium in cell culture incubator at a temperature of 37°C, and 5% of 
carbon dioxide. 
 
When 70-80% confluency was reached (2 - 3 days), the cells were divided to 
grow in a 3 fold of its growth surface area. First, the old culture medium was 
pipetted out. The cells were then detached from the bottom of the plate using 
hypertonic salt solution (40 mM Tris-HCl, 1 mM EDTA and 250 mM NaCl, pH 
7.4) warmed to 37°C in a water bath. The mixture of cultured cells and 






supernatant was discarded. A warmed fresh culture medium (37°C) was then 
added on the cell pellet to have homogenous suspension that was transferred 
evenly to a new 100 mm cell culture dishes and completed with fresh culture 
medium reaching a total volume of 10 ml. Growth conditions in the incubator 
where the dishes are placed remain the same with a temperature of 37°C, and 
5% of carbon dioxide. 
 
5.2 Plasmid DNA transformation and growth of bacteria 
  
A compatible and competent DH5α E.coli strain was transformed with pRK5 
plasmid expressing antibiotic resistance gene and containing the needed rat 
GABAA receptor cDNA (α6, β1, β2, β3, γ2 or δ) (Schofield et al, 1987; . Shivers 
et al., 1989; Ymer et al., 1989; Lüddens et al., 1990). 
  
The plasmid ligation mixture (1 µl) was pipetted into Eppendorf tube on ice bath 
followed by addition of 100 µl DH5α E.coli thawed on ice and the mixture was 
kept on ice for 20 min. Heat shock was induced by incubation in 42°C water 
bath for 90 seconds and then transferred back to the ice bath for 5 min. The 
bacterial culture was then plated  using a L-shaped spreader, on a 90 mm 
ampicillin-containing Lysogeny broth (LB) agar (Biokar diagnostics, Beauvais, 
France) culture plate (Sterilin, Newport, England) and grown for 12 h in a non-
sterilized incubator at 37°C. An individual colony was then picked with a 
disposable plastic loop and added to separate tube with 3 ml of ampicillin 
containing LB media (Yeast extract 5 g, Tryptone 10 g, NaCl 10 g, Milli-Q water 
1 liter and ampicillin 100 mg) leaving it to grow with shaking for 8 h (37°C, 250 
rpm). The tube contents were then added to ampicillin-containing LB media 
(500 ml) and incubated in a flask with shaking for 12 h (37°C, 250 rpm). The 
transformed bacteria were then centrifuged (6000 rpm, 30 mins. 4°C) after 
which the plasmids were isolated and purified. 
 
5.3 Plasmid purification 
  
Plasmids were purified by NucleoBond Xtra Maxi Plasmid and Xtra Maxi EF 
DNA Purification kits. (Macherey-Nagel GmbH & CO.KG, Düren, Germany) as 
per user manual instructions. The bacterial cell pellet was resuspended in RES 






Proteins, as well as chromosomal and plasmid DNA were denatured under 
these conditions. RNA was degraded by DNase-free RNase A. A neutralization 
buffer (NEU), containing potassium acetate, was added to the lysate, causing 
sodium dodecyl sulphate (SDS) to precipitate as KDS (potassium dodecyl 
sulfate) and pulling down proteins, chromosomal DNA, and other cellular debris. 
The potassium acetate buffer also neutralizes the lysate. Plasmid DNA are 
reverted to its native supercoiled structure and remained in solution. 
  
The lysate was then cleared and loaded onto the equilibrated acidic column 
filter (pH 6.5). The anion exchange column consists of hydrophilic, macroporous 
silica beads functionalized with positively charged methylaminoethanol (MAE) in 
which under acidic pH conditions it permits the negatively charged phosphate 
backbone of plasmid DNA to bind with high specificity. Plasmid DNA was then 
eluted from the column with an alkaline elution buffer (pH 9.0) to neutralize 
MAE charge resulting in DNA separation from the column to be collected in a 
tube. 
  
The eluted plasmid was precipitated with 0.7 volumes of room temperature 
isopropanol and loaded onto a special silica membrane filter by means of a 30 
ml syringe. The membrane was washed with 70% ethanol (4 ml) and then dried 
by pressing air through the filter. Elution of pure DNA was carried out by loading 
400 µl of slightly alkaline low salt buffer TRIS (5 mM Tris/HCl, pH 8.5) in a 1 ml 
syringe and passing through the silica membrane for collection in Eppendorf 
tube. The eluted plasmid DNA was dissolved in 450 µl of sterile Milli-Q water 
and added to 1 ml of 70% ethanol and 50 µl of 3 M sodium acetate (pH 5.2) to 
precipitate the DNA. The tube was then centrifuged (16 000 x g for 10 min) and 
the supernatant was discarded. The pellet was left to dry for one hour and 
eventually dissolved in 1 ml of sterile Milli-Q water before final storage in -20°C. 
A sample of 2 µl was taken to determine the concentration using UV 










5.4 Gel electrophoresis 
  
The procedure is performed to validate the purified pRK5 plasmids and ensure 
that the analyzed plasmid contains the required cDNA encoding for the specific 
GABAA receptor subunit. Agarose gel concentration of 1 % was prepared by 
dissolving 0.5 g of agarose in a flask containing 50 ml of 1X TRIS-borate-EDTA 
(TBE) buffer (50 ml). The contents were dissolved under heat and kept to cool 
down to 40°C before careful addition of ethidium bromide (1 µl). The gel was 
poured carefully on the electrophoresis chamber tray and left to harden with 
ensuring of no bubble formation. For sample preparation, 1 µl of 10x restriction 
enzyme buffer was added to two sample tubes containing 1 µl and 0.1 µl of 
plasmid and completed with 7 µl of sterile Milli-Q water and XbaI restriction 
enzyme (1µl). After an incubation of 2 h at 37°C 6-fold loading buffer (2µl) was 
added to each sample tube before they are pipetted to the gel wells (10 µl of 
1Kb DNA ladder was used as a control). The gel including the samples were 
transferred in the electrophoresis chamber containing 1X TBE buffer and the 
electrophoresis was run at a constant voltage of 70 v for one hour. UV 
transilluminator was eventually used to visualize the separated DNA fragments 
in the gel (Figure 8). 
 
 
Fig. 8. Gel electrophoresis indicating the presence of rat beta1 cDNA in pRK5 
plasmid digested by XbaI restriction enzyme that generate fragments sized 4.7 






5.5 Transient expression of recombinant GABAAR subtypes 
 
Human embryonic kidney (HEK) 293 cells were transfected with rat cDNAs (α6, 
β1, β2, β3, γ2S, δ) in pRK5 plasmids (Uusi-Oukari et al., 2000) under the 
control of CMV promoter using calcium phosphate precipitation method 
essentially as described by Lüddens and Korpi (1997). The procedure took 
place 24 h after dividing the cells in a 3 fold of its growth surface area when a 
confluency of 50% is reached. The plasmids coding for the different receptor 
subunits were used in 1:1:1 ratio for transfections containing GABAAR subtypes 
α6β2γ2, α6β1δ, α6β2δ and α6β3δ. For each 100 mm culture plate, a 
transfection mixture was prepared containing 5 µg of each subunit plasmid , 
450 µl of sterile milli-Q water, 50 µl 2.5 M CaCl2 solution (J. Baker, Austin, TX, 
USA) and 500 µl 2x HBS buffer (pH 7.00). The mixture tube was inverted 3-4 
times and left to incubate for 90 seconds before pipetting dropwise around the 
culture plate. The transfected cells were transferred to grow in the cell culture 
incubator at a temperature of 37°C and carbon dioxide concentration of 5%. 
Fresh culture medium was replaced after 24 h and the cells were incubated for 
another 24 h before harvesting. The transfection efficiency of HEK293 cells was 
evaluated with plasmid GFP (green fluorescent protein) as its expression was 
visualized 48 h after transfection using a fluorescence microscope (Olympus 




Fig. 9. The expression of GFP protein on the transfected HEK293 cells 







5.6 Cell harvesting 
  
The cells were harvested 48 h after transfection. Culture medium was discarded 
and the cells were detached from the plates by pipetting in ice-cold buffer 
containing 10 mM Tris-HCl, pH 7.4, 0.15 M NaCl and 2 mM EDTA to be 
collected in a centrifugation tube on ice. The cell suspension was centrifuged at                     
47 800 x g for 10 min at +4 ºC before discarding the detaching solution. The 
cells were either suspended in assay buffer (10 mM Tris-HCl, pH 7.4) to be 
used directly for binding assays or suspended in a buffer containing 10 mM 
Tris-HCl, pH 7.4, glycerol 43% and 0.15 M NaCl to be stored frozen at -20 ºC 
for 24 h. 
 
5.7 Measurements of binding kinetics 
  
Radiolabeled [3H]GABA and [3H]muscimol binding assays for HEK293 cell 
homogenates were performed essentially as described in Kontturi et al. (2011), 
Uusi-Oukari & Korpi (1989; 1990), Uusi-Oukari (1992) and in Uusi-Oukari & 
Maksay (2006). [3H]GABA (30 Ci/mmol) was purchased from Moravek 
Biochemicals (Brea, CA, USA). [Methylene-3H]muscimol (22 Ci/mmol) was 
purchased from Perkin Elmer Life and Analytical Sciences (Boston, MA, USA). 
GABA was from Sigma Chemical Co. (St. Louis, MO, USA). All receptor 
subtypes studied were always included in the same experiment which was 
performed independently at least three times. 
 
The binding of [3H]GABA and [3H]muscimol (10 nM/ 20 nM) were measured in 
10 mM Tris-HCl, pH 7.4 assay buffer at room temperature (22 ºC) in a total 
volume of 300 µl. Four parallel samples were incubated with shaking for various 
time points (15 s, 30 s, 1 min, 2 min, 4 min, 8 min and 15 min) to measure 
association of the binding. These included 4 samples to determine the total 
binding and 4 samples to determine the nonspecific binding. In total binding 
tubes, 100 μl of buffer (10 mM Tris-HCl, pH 7.4) were added followed by 100 μl 
of cell homogenates and finally with 100 μl 3x10nM/ 3x20nM of [3H]GABA or 
[3H]muscimol. In non-specific binding tubes 100 μl of 3x100 μM GABA was 
added instead of buffer since GABA excess (≥1000 x) compared to muscimol 







The incubation was terminated by filtration of the samples with a Brandel Cell 
Harvester (model M-24, Gaithersburg, MD, USA) onto Whatman GF/B glass 
fiber filters (Whatman International Ltd., Maidstone, UK). The samples were 
rinsed twice with 4-5 ml of ice-cold assay buffer. Filtration and rinsing steps took 
a total time of 15 s. Air-dried filters were immersed in 3 ml of Optiphase HiSafe 
3 scintillation fluid (Perkin Elmer Life and Analytical Sciences, Boston, MA, 
USA) and radioactivity determined in a HIDEX liquid scintillation counter 
(HIDEX, Turku, Finland). The DPM (disintegration per minute) values of the 
liquid scintillation counter indicate the amount of radioactive ligand bound to the 
filters. 
  
To measure the dissociation of [3H]GABA or [3H]muscimol binding, the four 
parallel samples of cells were first preincubated at room temperature (22 ºC) in 
a total volume of 300 μl for 15 min with [3H]GABA or [3H]muscimol (10 nM/ 20 
nM) in the presence of 100 μM GABA in non-specific binding tubes. The 
dissociation was then started by adding 100 μl of 400 μM or GABA to the 
incubation mixtures in the total binding tubes to reach a final 100 μM GABA 
concentration in all tubes. The tubes were mixed and incubations at room 
temperature (22 ºC) were terminated at various time points (0 s, 30 s, 1 min, 3 
min, 10 min and 30 min) as described above. 
 
5.8 Data analysis 
  
DPM readings obtained from HIDEX liquid scintillation counter were converted 
to % of control values in the Excel spreadsheet program (Microsoft Corporation, 
Redmond, WA, USA). The mean of specific binding from all experiments were 
calculated for every time point. Prism 5 and Prism 6 software (GraphPad, San 
Diego, CA, USA) were used in statistical testing and curve fitting of the 
association and dissociation data. Nonlinear regression analysis were used for 
estimation of kon and koff. To calculate koff (M
-1min-1), the dissociation values 
were fitted to the one phase exponential decay equation. The association 
values were fitted to one phase exponential association equation to calculate 
kob (observed association rate constant). kon (min
-1) was calculated with the 







The significance difference in association and dissociation curves between 
recombinant receptor subtypes were assessed by two-way repeated measures 
ANOVA followed by Bonferroni post hoc test. Furthermore, the statistical 
comparison of kon and koff values were performed with two tailed unpaired t-test 
and one-way ANOVA followed by Tukey’s post hoc test. P-values of less than 
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CGC: Cerebellar granule cells 
DGC: Dentate granule cells  
DPM: Disintegration per minute 
GABAAR: -Aminobutyric acid type A receptor  
HEK293: Human embryonic kidney cells 293 
KD: Equilibrium dissociation constant  
kon:  Association rate constant   
koff:  Dissociation rate constant 
MSE: mean squared error  
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